The latest financial statement is for the year ending 2025-12-31.
| Cash Flow | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Net income | 872,700 | 760,200 | 642,500 | 276,600 |
| (income) loss from discontinued operations | - | - | 0 | 0 |
| Deferred tax expense (benefit) | 101,400 | 244,900 | -108,500 | 63,800 |
| Depreciation and amortization | 250,000 | 223,500 | 196,400 | 182,000 |
| Net realized losses on investments, including impairment losses | -71,800 | -75,800 | -68,700 | -179,700 |
| Loss (gain) on extinguishment of debt | -1,300 | 0 | 100 | -900 |
| Restructuring costs | 27,300 | 5,400 | 34,300 | 41,800 |
| Loss on sale of business | -10,700 | -8,600 | - | - |
| Stock based compensation expense | 85,700 | 81,100 | 75,100 | 62,600 |
| Other intangible asset impairment | - | - | 0 | 0 |
| Goodwill impairment | - | 0 | 0 | 7,800 |
| Ik related charges, net of derivative gains | - | - | - | 0 |
| Insurance policy reserves and expenses | -266,300 | 1,192,200 | 9,400 | 1,877,300 |
| Premiums and accounts receivable | -95,700 | -172,800 | -120,600 | 465,600 |
| Commissions payable | 72,600 | 36,600 | -92,600 | -30,700 |
| Reinsurance recoverable | -627,600 | 892,200 | -345,600 | 809,500 |
| Reinsurance balance payable | - | 69,700 | -68,500 | 41,700 |
| Funds withheld under reinsurance | 12,700 | 112,600 | -25,400 | -4,900 |
| Deferred acquisition costs and value of business acquired (note 12 and 15) | 136,500 | 26,800 | 81,900 | 552,200 |
| Taxes receivable | -4,200 | -116,500 | -92,900 | 88,200 |
| Other assets and other liabilities | -11,600 | 324,200 | -95,900 | 349,900 |
| Other | -25,200 | 65,800 | 31,300 | 22,500 |
| Net cash provided by operating activities - discontinued operations | - | - | 0 | 0 |
| Net cash provided by operating activities | 1,833,900 | 1,332,700 | 1,138,100 | 596,900 |
| Fixed maturity securities available for sale | 1,188,000 | 1,330,900 | 1,464,600 | 2,468,800 |
| Equity securities | 43,500 | 87,600 | 52,700 | 52,300 |
| Other invested assets | 60,900 | 91,600 | 90,700 | 144,700 |
| Subsidiary, net of cash transferred | 0 | -5,000 | 0 | 4,800 |
| Ik foreign currency hedge | - | - | - | 0 |
| Fixed maturity securities available for sale | 807,100 | 564,400 | 280,200 | 483,600 |
| Commercial mortgage loans on real estate | 71,800 | 40,600 | 20,400 | 40,500 |
| Fixed maturity securities available for sale | 3,082,200 | 2,286,800 | 2,146,800 | 3,059,900 |
| Equity securities | 32,100 | 60,900 | 3,400 | 27,300 |
| Commercial mortgage loans on real estate | 56,000 | 57,200 | 55,600 | 80,300 |
| Other invested assets | 110,100 | 101,900 | 49,300 | 111,800 |
| Property and equipment and other | 235,500 | 221,300 | 202,500 | 186,300 |
| Subsidiary, net of cash transferred | 23,500 | 12,900 | 300 | 72,500 |
| Net cash outflow related to sale of interests in ik and termination of put/call obligations | - | - | - | 0 |
| Purchases of investments | - | - | - | 0 |
| Sale of investments | - | - | - | 0 |
| Change in short-term investments | 95,700 | 27,000 | 90,800 | -80,700 |
| Other | -6,000 | -100 | -2,400 | -600 |
| Net cash used in investing activities - discontinued operations | - | - | 0 | 0 |
| Net cash used in investing activities | -1,457,800 | -657,800 | -637,700 | -262,100 |
| Issuance of debt, net of issuance costs (note 19) | - | - | - | 0 |
| Issuance of debt, net of issuance costs (note 18) | 298,000 | 0 | 173,200 | - |
| Repayment of debt | - | - | 225,000 | 75,900 |
| Repayment of debt for consolidated investment entities | - | - | - | 0 |
| Borrowing under unsecured revolving credit facility | - | - | - | 0 |
| Repayment of debt | 176,300 | 0 | - | - |
| Payments on unsecured revolving credit facility | - | - | - | 0 |
| Payment of contingent liability | 0 | 0 | 2,500 | - |
| Acquisition of common stock | 303,700 | 307,400 | 193,100 | 572,800 |
| Common stock dividends paid | 168,400 | 155,900 | 152,300 | 150,200 |
| Preferred stock dividends paid | - | - | 0 | 0 |
| Employee stock purchases and withholdings | - | - | - | 19,500 |
| Proceeds repaid on transfer of rights to aca recoverable (note 4) | - | - | - | 0 |
| Employee stock purchases and withholdings | 13,800 | 14,200 | 4,200 | - |
| Net cash used in financing activities | -364,200 | -477,500 | -403,900 | -818,400 |
| Effect of exchange rate changes on cash and cash equivalents - continuing operations | - | - | -5,800 | -34,500 |
| Effect of exchange rate changes on cash and cash equivalents - discontinued operations | - | - | 0 | 0 |
| Effect of exchange rate changes on cash and cash equivalents | 14,500 | -17,100 | -5,800 | -34,500 |
| Change in cash and cash equivalents | 26,400 | 180,300 | 90,700 | -518,100 |
| Statement table | - | 0 | 0 | 0 |
| Cash and cash equivalents at beginning of period | - | 1,627,400 | 1,536,700 | 2,054,800 |
| Cash and cash equivalents at end of period | - | 1,807,700 | 1,627,400 | 1,536,700 |
| Less cash and cash equivalents reclassified as held for sale at end of period | - | - | 0 | 0 |
| Less cash and cash equivalents of discontinued operations at end of period | - | - | - | 0 |
| Cash and cash equivalents at beginning of period - continuing operations | 1,807,700 | - | - | - |
| Cash and cash equivalents of continuing operations at end of period | 1,834,100 | - | 1,627,400 | 1,536,700 |
ASSURANT, INC. (AIZN)
ASSURANT, INC. (AIZN)